Pharmacologic treatments for esophageal disorders

L Ashley Blackshaw, Dmitry S Bordin, Christina Brock, Anne Brokjaer, Asbjørn Mohr Drewes, Adam D Farmer, Anne Petas Swane Krarup, Christian Lottrup, Antonina A Masharova, Fouad J Moawad, Anne Estrup Olesen

Research output: Contribution to journalConference article in JournalResearchpeer-review

9 Citations (Scopus)


The following, from the 12th OESO World Conference: Cancers of the Esophagus, includes commentaries on the role for ketamine and other alternative treatments in esophageal disorders; the use of linaclotide in the treatment of esophageal pain; the alginate test as a diagnostic criterion in gastroesophageal reflux disease (GERD); the use of baclofen in treatment of GERD; the effects of opioids on the esophagus; the use of antagonists on the receptor level in GERD; the effect of local formulation of drugs on the esophageal mucosa; and the use of electroencephalographic fingerprints to predict the effect of pharmacological treatment.

Original languageEnglish
JournalAnnals of the New York Academy of Sciences
Issue number1
Pages (from-to)23-39
Number of pages17
Publication statusPublished - 2014
Event OESO World Conference: Cancers of the Esophagus - Paris, France
Duration: 27 Aug 201330 Jun 2014
Conference number: 12th


Conference OESO World Conference


Dive into the research topics of 'Pharmacologic treatments for esophageal disorders'. Together they form a unique fingerprint.

Cite this